NCT05111873

Brief Summary

The observational study aims to investigate the effects of a multimodal treatment program for headache patients in a day clinic service. The setting provides one week of treatment including a combination of medical consultation, physiotherapy, psychological therapy, occupational therapy, progressive muscle relaxation and disease specific education. Outcome measures are the disease-specific impact on daily activities, general quality of life, psychological impact and headache frequency. Moreover, the study sought to identify parameters that best predict efficacy of the intervention. Therefore, standardized questionnaires are established in three points in time, to evaluate the pre- and post-treatment status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

November 8, 2021

Status Verified

October 1, 2021

Enrollment Period

1.2 years

First QC Date

July 12, 2021

Last Update Submit

October 26, 2021

Conditions

Keywords

multimodal treatmentquality of lifeday clinic service

Outcome Measures

Primary Outcomes (1)

  • Change of Veterans RAND 12 Item Health Survey (VR-12) mental health score

    questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

Secondary Outcomes (5)

  • Change of Depression Anxiety and Stress Scale (DASS)

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

  • Change of Headache Impact Test (HIT6)

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

  • Change of Pain intensity

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

  • Change of Headache frequency

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

  • Change of Veterans RAND 12 Item Health Survey (VR-12) physical health score

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

Other Outcomes (1)

  • Change of Veterans RAND 12 Item Health Survey (VR-12) single domains

    4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

Study Arms (2)

waiting-list control

Participants enquired prior to the treatment appointment in the neurological day clinic service, no intervention

post-treatment group

Participants enquired after the treatment in the Neurological day clinic service

Other: multimodal treatment

Interventions

combination of medical consultations, psychological therapy, physiotherapy, occupational therapy, disease specific education und progressive muscle relaxation

post-treatment group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients seen in the neurological day clinic service will be screened for eligibility.

You may qualify if:

  • diagnosis of a headache disorder
  • written informed consent for collecting and analysing data and conducting a follow-up evaluation

You may not qualify if:

  • premature interruption of the treatment
  • repeated treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology

Greifswald, Mecklenburg-Vorpommern, 17475, Germany

RECRUITING

MeSH Terms

Conditions

Headache Disorders

Interventions

Combined Modality Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2021

First Posted

November 8, 2021

Study Start

February 15, 2021

Primary Completion

April 30, 2022

Study Completion

May 30, 2022

Last Updated

November 8, 2021

Record last verified: 2021-10

Locations